MetLife, Inc.’s MET institutional asset management arm, MetLife Investment Management (“MIM”), recently launched its second private equity fund, MetLife Investment Private Equity Partners II, securing around $1.2 billion in commitments. This new fund, aimed at institutional clients, includes a portfolio of about $860 million in private equity and co-investment interests. Combined with funded and unfunded commitments, the total reaches $975 million. The transaction was anchored by Lexington Partners L.P., the lead investor in the project. MIM also plans to utilize $250 million on new private equity opportunities. The successful closing of this fund highlights MIM's expanding capabilities and leadership in private markets. This strategic move follows the strong performance of MetLife’s private equity investments, which, at first quarter-end, held $14.3 billion in assets. The private equity team of MIM alone has invested more than $20 billion in alternative investments in the 2010-2023 period. The deal was advised by Evercore, and it further underscores MIM's commitment to offer tailored investment solutions to institutional investors around the globe. It had $593.7 billion in assets under management as of the first quarter-end. This move will likely expand MIM's private equity platform and attract more institutional investors, boosting MetLife's assets under management and overall financial growth. The overall resilience of the economy offers a stable backdrop for launching new investment vehicles. Investors are seeking diversification and strong returns in private equity, maintaining high demand for such investments among institutional investors. Given the strong long-term performance of MIM’s private equity investments, this seems like an opportune moment to leverage its track record. Price Performance MetLife’s shares have gained 20.9% in the past year compared with the 21.6% growth of the industry it belongs to. Zacks Investment Research Image Source: Zacks Investment Research Zacks Rank & Key Picks MetLife currently has a Zacks Rank #3 (Hold). Investors interested in the broader Finance space may look at some better-ranked players like Root, Inc. ROOT, Brown & Brown, Inc. BRO and EverQuote, Inc. EVER. While Root currently sports a Zacks Rank #1 (Strong Buy), Brown & Brown and EverQuote carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here. The consensus mark for ROOT’s current-year earnings indicates a 60.6% year-over-year improvement. It beat earnings estimates in all the past four quarters, with an average surprise of 34.1%. Furthermore, the consensus estimate for Root’s 2024 revenues suggests 125.3% year-over-year growth. The Zacks Consensus Estimate for Brown & Brown’s current-year earnings is pegged at $3.61 per share, which indicates 28.5% year-over-year growth. It has witnessed one upward estimate revision against none in the opposite direction during the past 60 days. BRO beat earnings estimates in each of the past four quarters, with an average surprise of 11.9%. The consensus mark for EverQuote’s current-year earnings indicates a 103.3% year-over-year improvement. It beat earnings estimates in all the past four quarters, with an average surprise of 65.2%. Furthermore, the consensus estimate for EVER’s 2024 revenues suggests 33.9% year-over-year growth. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MetLife, Inc. (MET):Free Stock Analysis Report Brown & Brown, Inc. (BRO):Free Stock Analysis Report EverQuote, Inc. (EVER):Free Stock Analysis Report Root, Inc. (ROOT):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
MetLife (MET) Arm MIM Secures $1.2B for 2nd Private Equity Fund
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...